Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin Katherine CoxMerhawit GhebrehiwetMatt Vassar Systematic Review 10 January 2023 Pages: 85 - 95
Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies S Sajith KumarBhavani Shankara BagepallyAkhil Sasidharan Systematic Review 09 January 2023 Pages: 97 - 108
Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis Nadine WentzellBianca KollhorstUlrike Haug Original Research Article Open access 21 December 2022 Pages: 109 - 117
Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus Leona Plum-MörschelLizette Ravn AndersenHanne Haahr Original Research Article Open access 11 January 2023 Pages: 119 - 127
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System Toru OguraChihiro Shiraishi Original Research Article 13 January 2023 Pages: 129 - 140
Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database Jami WangMollie F. QianJoyce M. C. Teng Short Communication 10 January 2023 Pages: 141 - 145
Comment on: “Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” Deep DuttaRitin MohindraAnoop Misra Letter to the Editor 13 January 2023 Pages: 147 - 148
Response to Comment on: “Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” Devarapalli Ranjani DurgaNadella MounikaRamu Adela Letter to the Editor 12 January 2023 Pages: 149 - 150
Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece George GourzoulidisMaria KoulentakiGeorgia Kourlaba Correction 29 December 2022 Pages: 151 - 151
Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends Arnaldo FigueiredoLuís CostaCarlos Martins-da-Silva Correction Open access 27 January 2023 Pages: 153 - 154
